人胶质母细胞瘤组织中的吉非替尼浓度。 - Suppr

Gefitinib concentrations in human glioblastoma tissue.

作者信息

Hofer Silvia, Frei Karl

机构信息

Medical Oncology, University Hospital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.

出版信息

J Neurooncol. 2007 Apr;82(2):175-6. doi: 10.1007/s11060-006-9257-3. Epub 2006 Sep 29.

DOI:10.1007/s11060-006-9257-3

PMID:17008949

Abstract

摘要

相似文献

Gefitinib concentrations in human glioblastoma tissue.

J Neurooncol. 2007 Apr;82(2):175-6. doi: 10.1007/s11060-006-9257-3. Epub 2006 Sep 29.

Gefitinib accumulation in glioblastoma tissue.

Cancer Biol Ther. 2006 May;5(5):483-4. doi: 10.4161/cbt.5.5.2653. Epub 2006 May 5.

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.

Cancer Chemother Pharmacol. 2010 Jan;65(2):353-61. doi: 10.1007/s00280-009-1041-6.

Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma.

Cancer Res. 2013 Aug 15;73(16):5242-52. doi: 10.1158/0008-5472.CAN-13-0690. Epub 2013 Jun 24.

Analytical approach to characterize the intratumoral pharmacokinetics and pharmacodynamics of gefitinib in a glioblastoma model.

J Pharm Sci. 2012 Nov;101(11):4100-6. doi: 10.1002/jps.23283. Epub 2012 Aug 1.

Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib.

Mol Cancer Ther. 2009 Jun;8(6):1438-47. doi: 10.1158/1535-7163.MCT-09-0089. Epub 2009 Jun 9.

β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.

Int J Oncol. 2016 Oct;49(4):1427-36. doi: 10.3892/ijo.2016.3626. Epub 2016 Jul 21.

Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.

Clin Pharmacokinet. 2005;44(10):1067-81. doi: 10.2165/00003088-200544100-00005.

CYP3A phenotyping approach to predict systemic exposure to EGFR tyrosine kinase inhibitors.

J Natl Cancer Inst. 2006 Dec 6;98(23):1714-23. doi: 10.1093/jnci/djj466.

Bioactivation of the epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicities.

Chem Res Toxicol. 2009 Oct;22(10):1736-42. doi: 10.1021/tx900256y.

引用本文的文献

The blood-tumour barrier in cancer biology and therapy.

Nat Rev Clin Oncol. 2021 Nov;18(11):696-714. doi: 10.1038/s41571-021-00529-6. Epub 2021 Jul 12.

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography.

EJNMMI Res. 2019 Dec 12;9(1):110. doi: 10.1186/s13550-019-0581-y.

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175.

Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.

Oncologist. 2017 Feb;22(2):222-235. doi: 10.1634/theoncologist.2016-0117. Epub 2017 Feb 6.

Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Clin Pharmacokinet. 2016 Mar;55(3):297-311. doi: 10.1007/s40262-015-0319-6.

Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma.

Cancer Res. 2013 Aug 15;73(16):5242-52. doi: 10.1158/0008-5472.CAN-13-0690. Epub 2013 Jun 24.

Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma.

Neuro Oncol. 2013 Aug;15(8):1048-57. doi: 10.1093/neuonc/not053. Epub 2013 Jun 7.

Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma.

Drug Metab Dispos. 2013 Jan;41(1):33-9. doi: 10.1124/dmd.112.048322. Epub 2012 Sep 26.

Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents.

Mol Cancer Ther. 2012 Oct;11(10):2183-92. doi: 10.1158/1535-7163.MCT-12-0552. Epub 2012 Aug 13.

MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.

Mol Cancer Ther. 2012 Jan;11(1):154-64. doi: 10.1158/1535-7163.MCT-11-0606. Epub 2011 Nov 4.

本文引用的文献

Gefitinib accumulation in glioblastoma tissue.

Cancer Biol Ther. 2006 May;5(5):483-4. doi: 10.4161/cbt.5.5.2653. Epub 2006 May 5.

Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 May 5;819(1):73-80. doi: 10.1016/j.jchromb.2005.01.027.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Gefitinib concentrations in human glioblastoma tissue.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献